Myriad Genetics, Inc. company mark

Myriad Genetics, Inc. Annual Report 2026

Official Filings · AI Report coming soon
Official Annual + Quarterly Filings
NASDAQ/NYSE: MYGN
Sector: Healthcare
Industry: Diagnostics & Research
Market Cap $0.29B
Source: SEC EDGAR
Business Intelligence Report
Not generated yet

Quality Scores

Business
Compounder
Management
Governance
Cash Flow
AI Quality Scores locked
Sign In to Generate One →

Latest Quarterly Earnings Summary

No quarterly summary yet

Generate the Business Intelligence Report to unlock AI earnings summary.

Sign In to Generate One →
Loading latest Annual Report…

Myriad Genetics, Inc. Business Intelligence Hub

The Myriad Genetics, Inc. Business Intelligence Hub is your central gateway to AI-powered company research, fundamental analysis, and equity research on Myriad Genetics, Inc.. This page always opens the latest Business Intelligence annual report and stays in sync with Myriad Genetics, Inc.'s newest 10-K filings, quarterly results and management commentary — so you're never reading stale analysis.

Myriad Genetics, Inc. Financial Performance & Statements

Explore Myriad Genetics, Inc.'s financial statements, revenue growth, net profit, EPS, book value, free cash flow and net worth trends over 5 and 10 years — with deterministic AI-validated numbers, not hallucinated summaries.

Myriad Genetics, Inc. Quarterly Earnings & Management Commentary

Read the latest Myriad Genetics, Inc. quarterly results, earnings summary, management commentary and concall highlights — cross-checked against the official filing.

Myriad Genetics, Inc. Growth, Governance & Cash Flow Analysis

AI-graded scores on business compounding, compounder quality, management credibility, corporate governance and cash flow strength — the pillars of long-term business quality.

Myriad Genetics, Inc. Sector, Valuation & Risk Analysis

See Myriad Genetics, Inc. in context: sector analysis, industry analysis, competitive position, capital allocation, valuation context and key risks — surfaced from a decade of annual reports.

Related searches: Myriad Genetics, Inc. annual report, Myriad Genetics, Inc. AI annual report, Myriad Genetics, Inc. fundamental analysis, Myriad Genetics, Inc. business analysis, Myriad Genetics, Inc. financial performance, Myriad Genetics, Inc. financial statements, Myriad Genetics, Inc. growth analysis, Myriad Genetics, Inc. management analysis, Myriad Genetics, Inc. corporate governance, Myriad Genetics, Inc. cash flow analysis, Myriad Genetics, Inc. business intelligence, Myriad Genetics, Inc. valuation, Myriad Genetics, Inc. quarterly results, Myriad Genetics, Inc. earnings summary, Myriad Genetics, Inc. management commentary, Myriad Genetics, Inc. sector analysis, Myriad Genetics, Inc. company research, Myriad Genetics, Inc. equity research, Myriad Genetics, Inc. stock analysis, Myriad Genetics, Inc. AI company analysis, Myriad Genetics, Inc. capital allocation, Myriad Genetics, Inc. risk analysis, Myriad Genetics, Inc. competitive position, Myriad Genetics, Inc. long-term growth.